Autism Spectrum Disorder. Autistic disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: psychiatrist –diagnosed ASD (by Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-V)) Male gender aged 6-8 years no change in any medical, dietary or behavior treatment during the study parental informed consent
Exclusion criteria
Exclusion criteria: Having comorbid disability or other Neuro-cognitive disorders receiving vitamin D supplements in the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL-1B serum levels. Timepoint: One week before starting and one week after terminating of intervention. Method of measurement: Diaclone human kit for IL-1B.;IL-1ra serum levels. Timepoint: One week before starting and one week after terminating of intervention. Method of measurement: ZellBio human kit for IL-1RA.;Vitamin D serum level. Timepoint: One week before starting and one week after terminating of intervention. Method of measurement: Pars Azmoon human kit.;Stereotypic behavior. Timepoint: One week before starting and one week after terminating of intervention. Method of measurement: Gars-2, stereotypic behaviors subscale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University